Subscribe To
Fiscalnote to present at the 25th annual needham growth conference on january 10, 2023
WASHINGTON--( BUSINESS WIRE )-- FiscalNote Holdings, Inc . (NYSE: NOTE) ("FiscalNote"), a leading AI-driven enterprise Software-as-a-Service (“SaaS�...
January 5, 2023, 7:01 am
Tremor international to present at the needham growth conference
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tremor International Ltd. (AIM/NASDAQ: TRMR) (“Tremor” or the “Company”), a global leader in data...
January 5, 2023, 6:30 am
Semrush holdings, inc. to present at the needham growth conference
BOSTON--( BUSINESS WIRE )--Semrush Holdings, Inc. (NYSE: SEMR), a leading online visibility management SaaS platform, announced today that Evgeny Feti...
January 4, 2023, 4:30 pm
Upwork to participate in 25th annual needham growth conference
SAN FRANCISCO, Jan. 03, 2023 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with ind...
January 3, 2023, 9:10 pm
Cyclacel pharmaceuticals to present at biotech showcase and participate in a corporate access event during the j.p. morgan healthcare conference in january 2023
BERKELEY HEIGHTS, N.J., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...
December 15, 2022, 9:15 am
Broadridge to participate in investor conference
NEW YORK , Dec. 2, 2022 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) announced that Edmund Reese, Chief Financial Officer, will be ...
December 2, 2022, 6:25 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Widepoint to present at the ladenburg thalmann virtual tech expo 22 on wednesday, december 7, 2022
FAIRFAX, VA / ACCESSWIRE / November 28, 2022 / WidePoint Corporation (NYSE American:WYY), the innovative technology Managed Solution Provider (MSP) sp...
November 28, 2022, 9:25 am
Spero therapeutics to present at the 5th annual evercore isi healthconx conference
CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical c...
November 22, 2022, 8:05 am
Larimar therapeutics to present at the 34th annual piper sandler healthcare conference
BALA CYNWYD, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company ...
November 21, 2022, 4:05 pm
Cardiff oncology to present at upcoming investor conferences
SAN DIEGO , Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to ...
November 21, 2022, 10:52 am